Equibles does not estimate personal net worth.
Get an email with a short summary when Agios Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.
Get AGIO alertsBrian Gough is recorded as CEO at Agios Pharmaceuticals, Inc. (AGIO). Brian Gough has spoken on 2 earnings calls across 1 company, most recently for Agios Pharmaceuticals, Inc. on November 5, 2026. Agios Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Agios Pharmaceuticals, Inc. includes Brian Goff (CEO and Board Member), Jacqualyn Fouse (CEO and Board Member), David P. Schenkein (Chairman) and 7 others.
“The third quarter delivered record product revenue for Agios and is a clear demonstration of our commercial execution. We delivered $55.4 million in total net revenue, more than four times the third quarter of last year.”
“Just last month, we outlined our 2026 strategic priorities, which are focused on delivering long-term shareholder value.”
Biotechnology · Healthcare
CEO
